Literature DB >> 3757721

Myoelectric and contractile effects of motilin on dog small intestine in vivo.

I M Lang, S K Sarna, R E Condon.   

Abstract

The effects of the close intraarterial administration of motilin on intestinal myoelectric and contractile activities were examined in 37 dogs. After anesthetization or decerebration, a segment of proximal jejunum was instrumented serosally with electrodes and stain gauges. A mesenteric artery supplying a short length of this segment was cannulated for the injection of motilin and other agents. Motilin (0.03-0.3 microgram) caused: a series (1-5 min) of phasic contractions and electrical response activity (ERA) bursts locally; a short (15-60 sec) series of phasic contractions and ERA bursts aborally followed by relaxation; and a series of phasic contractions and ERA bursts whose onset migrated 3.7 +/- 1.0 cm orally. The length of orad response increased to 6.6 +/- 1.9 cm in the decerebrate dogs (P less than 0.01). No other tested agent, including serotonin, bethanechol, morphine, dopamine, substance P, neurotensin, somatostatin, vasoactive intestinal peptide, bombesin, pentagastrin, cholecystokinin octapeptide, prostaglandin F2 alpha or leucine-enkephalin, caused similar responses. All motilin responses were mediated by neural pathways consisting of both nicotinic and muscarinic receptors. The similarity of responses and mechanisms of action of the motilin-activated contractile response with the intrinsic mucosal reflex suggested that motilin may mediate this reflex.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3757721     DOI: 10.1007/bf01300259

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  34 in total

1.  Intestinal motility increased by tetrodotoxin, lidocaine, and procaine.

Authors:  B Biber; J Fara
Journal:  Experientia       Date:  1973-05-15

2.  Studies on the role of serotonin in the inhibition of gastric acid secretion by the duodenum.

Authors:  L Wise; J Burkholder; A Zagaloff; M Schuck; W F Ballinger
Journal:  Ann Surg       Date:  1968-11       Impact factor: 12.969

3.  Characterization of motilin induced contractions of the isolated canine intestine.

Authors:  L D Hirning; T F Burks
Journal:  Proc West Pharmacol Soc       Date:  1983

4.  Ultrastructural evidence for an innervation of epithelial enterochromaffine cells in the guinea pig duodenum.

Authors:  J M Lundberg; A Dahlström; A Bylock; H Ahlman; G Pettersson; I Larsson; H A Hansson; J Kewenter
Journal:  Acta Physiol Scand       Date:  1978-09

5.  Changes in plasma motilin concentration and gastrointestinal contractile activity in conscious dogs.

Authors:  Z Itoh; S Takeuchi; I Aizawa; K Mori; T Taminato; Y Seino; H Imura; N Yanaihara
Journal:  Am J Dig Dis       Date:  1978-10

6.  Gastroduodenal motor response to natural motilin and synthetic position 13-substituted motilin analogues: a comparative in vitro study.

Authors:  U Strunz; W Domschke; S Domschke; P Mitznegg; E Wünsch; E Jaeger; L Demling
Journal:  Scand J Gastroenterol       Date:  1976       Impact factor: 2.423

7.  The diffuse endocrine-paracrine system of the gut in health and disease: ultrastructural features.

Authors:  E Solcia; C Capella; R Buffa; L Usellini; R Fiocca; B Frigerio; P Tenti; F Sessa
Journal:  Scand J Gastroenterol Suppl       Date:  1981

8.  Relationship between porcine motilin-induced migrating motor complex-like activity, vagal integrity, and endogenous motilin release in dogs.

Authors:  K E Hall; G R Greenberg; T Y El-Sharkawy; N E Diamant
Journal:  Gastroenterology       Date:  1984-07       Impact factor: 22.682

9.  Motilin-induced mechanical activity in the canine alimentary tract.

Authors:  Z Itoh; R Honda; K Hiwatashi; S Takeuchi; I Aizawa; R Takayanagi; E F Couch
Journal:  Scand J Gastroenterol Suppl       Date:  1976

10.  Mechanisms of the secretory and motor responses of the Brunner's gland region of the intestines to duodenal acidification.

Authors:  I M Lang; M F Tansy
Journal:  Pflugers Arch       Date:  1983-02       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.